What are the recommended treatment options for dysmenorrhea?

Treatment Options for Dysmenorrhea

NSAIDs are the first-line pharmacologic treatment for dysmenorrhea, with hormonal contraceptives as an equally effective first-line option that can be used independently or in combination with NSAIDs. 1, 2, 3

First-Line Pharmacologic Treatments

NSAIDs (Nonsteroidal Anti-Inflammatory Drugs)

• NSAIDs work by inhibiting cyclooxygenase enzymes, thereby blocking prostaglandin formation, which is the primary pathophysiologic mechanism causing myometrial contraction and vasoconstriction in dysmenorrhea 1
• Recommended duration: 5-7 days of treatment 4
• Specific NSAIDs with evidence include ibuprofen, mefenamic acid, and celecoxib 4
• NSAIDs should be initiated at the onset of menstrual pain for maximum effectiveness 3

Hormonal Contraceptives

• Combined hormonal contraceptives (CHCs) and progestin-only pills (POPs) are equally effective as NSAIDs and should be selected based on contraceptive needs and patient preferences 2, 3
• Combined oral contraceptives can be used in standard cyclic regimens or extended/continuous regimens 4
• Other hormonal options include the levonorgestrel-releasing intrauterine system (LNG-IUD), depot medroxyprogesterone acetate (DMPA), and contraceptive implants 4
• For patients desiring contraception, hormonal methods provide dual benefit for both dysmenorrhea management and pregnancy prevention 2

Combination Therapy

• NSAIDs and hormonal contraceptives can be used together when monotherapy provides insufficient relief 2, 3

Second-Line Pharmacologic Options

For Refractory Cases

• Paracetamol (acetaminophen) can be considered, though evidence is less robust than for NSAIDs 1
• Gonadotropin-releasing hormone (GnRH) analogs are typically reserved for secondary dysmenorrhea due to endometriosis 1
• Dienogest (2 mg/day) may be considered for adenomyosis-related dysmenorrhea, though recent evidence suggests it may be less effective than interventional procedures 5

Non-Pharmacologic Treatments with Strong Evidence

Heat Therapy

• Topical heat application has good evidence for effectiveness and can be used as adjunctive therapy 2, 3

Physical Exercise

• Regular physical exercise demonstrates strong evidence for reducing dysmenorrhea symptoms 2, 3

Transcutaneous Electrical Nerve Stimulation (TENS)

• TENS has good evidence supporting its use and should be considered for patients who prefer non-pharmacologic approaches 2, 3

Self-Acupressure

• Self-acupressure shows good evidence and can be taught to patients for self-management 2

Alternative Therapies with Limited Evidence

These should be used in conjunction with first-line therapy after discussing risks and benefits:

• Dietary supplements 1, 3
• Acupuncture 1, 3
• Saffron supplementation shows promise in recent meta-analyses for both PMS and dysmenorrhea 6

Surgical Options

Reserved for severe dysmenorrhea refractory to medical management:

• Endometrial ablation 1
• Presacral neurectomy 1
• Laparoscopic uterosacral nerve ablation 1
• Uterine artery embolization for adenomyosis-related dysmenorrhea shows superior outcomes compared to medical management 5

Clinical Algorithm

1. Start with NSAIDs (5-7 days per cycle) for all patients with dysmenorrhea 4
2. Add or switch to hormonal contraceptives if NSAIDs alone are insufficient or if contraception is desired 2, 3
3. Combine NSAIDs with hormonal contraceptives for inadequate response to monotherapy 2
4. Incorporate non-pharmacologic therapies (heat, exercise, TENS) as adjunctive treatment at any stage 2, 3
5. Evaluate for secondary causes if pain is progressive, associated with abnormal bleeding, vaginal discharge, or dyspareunia 2
6. Consider surgical options only after failure of comprehensive medical management 1, 3

Important Caveats

• Always rule out pregnancy in sexually active patients before initiating treatment 2
• Secondary dysmenorrhea requires additional workup including pelvic examination and ultrasonography if suspected 2
• Referral to gynecology is warranted for suspected secondary causes or treatment-refractory cases 2
• Dysmenorrhea is significantly undertreated and underdiagnosed despite affecting 50-90% of reproductive-age women, with a global prevalence of 71.3% 2, 7